Nordea Investment Management Ab Bei Gene, Ltd. Transaction History

Nordea Investment Management Ab

  • $85.8 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$221.31 - $316.61 $326,432 - $466,999
-1,475 Closed
0 $0
Q3 2020

Nov 09, 2020
SELL
$189.18 - $286.44 $279,040 - $422,499
-1,475 Reduced 50.0%
1,475 $423,000
Q2 2020

Aug 13, 2020
BUY
$123.9 - $195.41 $365,505 - $576,459
2,950 New
2,950 $555,000
Q1 2020

May 15, 2020
SELL
$121.84 - $173.19 $159,001 - $226,012
-1,305 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$115.78 - $208.34 $151,092 - $271,883
1,305 New
1,305 $219,000
Q3 2019

Nov 13, 2019
SELL
$120.61 - $148.29 $128,811 - $158,373
-1,068 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$113.99 - $146.86 $11.3 Million - $14.6 Million
-99,122 Reduced 98.93%
1,068 $132,000
Q1 2019

May 20, 2019
SELL
$122.82 - $151.83 $61,410 - $75,915
-500 Reduced 0.5%
100,190 $13.2 Million
Q4 2018

Feb 14, 2019
BUY
$107.01 - $175.15 $2.84 Million - $4.65 Million
26,568 Added 35.84%
100,690 $14.1 Million
Q3 2018

Nov 14, 2018
BUY
$152.62 - $189.66 $11.3 Million - $14.1 Million
74,122 New
74,122 $12.8 Million
Q2 2018

Aug 13, 2018
SELL
$152.5 - $216.77 $9.8 Million - $13.9 Million
-64,240 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$97.41 - $177.22 $6.26 Million - $11.4 Million
64,240 New
64,240 $10.8 Million

Others Institutions Holding BGNE

# of Institutions
249
Shares Held
45.3M
Call Options Held
292K
Put Options Held
119K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $20.1B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email